We are live on ! Find out more
PBLA

Panbela Therapeutics, Inc. Common Stock
PBLA

Delisted

PBLA was delisted on the 6th of March, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of PBLA yet.

PBLA Hedge Fund Activity: Q1 2024 in Review

0 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Panbela Therapeutics, Inc. Common Stock (PBLA) for Q1 2024, worth a combined $0 — down 100% from $564K a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of PBLA and 0 opened new positions — a net loss of 10 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Goldman Sachs, exiting entirely with an estimated $449K sold.

  • 0 institutional investors held Panbela Therapeutics, Inc. Common Stock (PBLA) as of Q1 2024, down from 10 in Q4 2023.
  • Funds reported $0 of Panbela Therapeutics, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Panbela Therapeutics, Inc. Common Stock positions in Q1 2024 and 10 closed out, a net change of -10 holders.
  • The largest Panbela Therapeutics, Inc. Common Stock seller in Q1 2024 was Goldman Sachs, an estimated $449K sold.

Based on aggregated 13F filings for Q1 2024.